Publication | Closed Access
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial
74
Citations
28
References
2023
Year
The MRDs were successfully assessed using FCM. An MTX dose of 2 g/m<sup>2</sup> was effective in preventing relapse in non-HR pcB-ALL. Augmented IB showed no advantages over the standard IB.[Media: see text].
| Year | Citations | |
|---|---|---|
Page 1
Page 1